Evidence map›Paper›PMID 38449516›Full record

ArticleJAC-antimicrobial resistance2024

Enterococcal endocarditis management and relapses.

Nina Garofoli, Véronique Joly, Diane Le Pluart, Claire Amaris Hobson, Anne-Lise Beaumont, Sylvie Lariven, Nathalie Grall, Marylou Para, Yazdan Yazdanpanah, François-Xavier Lescure and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JAC-antimicrobial resistance, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Changing antimicrobial prescribing patterns, and laboratory reporting in Enterococcus faecalis infective endocarditis at a tertiary Australian centre.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  2. Article
  3. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Nina GarofoliUniversité Paris-Sud, Kremlin-Bicêtre, France.ORCID https://orcid.org/0009-0004-3631-1828
Véronique JolyInfectious and Tropical Diseases Department, Bichat-Claude-Bernard Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris Cité, Paris, France.
Diane Le PluartInfectious and Tropical Diseases Department, Bichat-Claude-Bernard Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris Cité, Paris, France.
Claire Amaris HobsonInfectious and Tropical Diseases Department, Bichat-Claude-Bernard Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris Cité, Paris, France.ORCID https://orcid.org/0000-0002-8800-270X
Anne-Lise BeaumontInfectious and Tropical Diseases Department, Bichat-Claude-Bernard Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris Cité, Paris, France.
Sylvie LarivenInfectious and Tropical Diseases Department, Bichat-Claude-Bernard Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris Cité, Paris, France.
Nathalie GrallBacteriology Laboratory, Hôpital Bichat-Claude-Bernard, Assistance Publique-Hôpitaux de Paris, Université Paris Cité, Paris, France.
Marylou ParaCardiology Department, Hôpital Bichat-Claude-Bernard, Assistance Publique-Hôpitaux de Paris, Université Paris Cité, Paris, France.ORCID https://orcid.org/0000-0002-4857-5474
Yazdan YazdanpanahInfectious and Tropical Diseases Department, Bichat-Claude-Bernard Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris Cité, Paris, France.
François-Xavier LescureInfectious and Tropical Diseases Department, Bichat-Claude-Bernard Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris Cité, Paris, France.
Nathan Peiffer-SmadjaInfectious and Tropical Diseases Department, Bichat-Claude-Bernard Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris Cité, Paris, France.
Laurène DeconinckInfectious and Tropical Diseases Department, Bichat-Claude-Bernard Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris Cité, Paris, France.
Michael ThyInfectious and Tropical Diseases Department, Bichat-Claude-Bernard Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris Cité, Paris, France.ORCID https://orcid.org/0000-0001-9366-505X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Methods: We conducted a monocentric, retrospective analysis of all patients hospitalized for EE including endocarditis or infection of cardiac implantable electronic device defined by the modified ESC 2015 Duke criteria in a referral centre in Paris, France. Results: Between October 2016, and September 2022, 54 patients with EE were included, mostly men ( Conclusions: EE is a worrying disease associated with a high risk of relapse and significant mortality. Suppressive antibiotic therapy could be a key treatment to limit the occurrence of relapses.

Identifiers

PMID38449516
PMCPMC10915900

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.